54
Participants
Start Date
September 30, 2010
Primary Completion Date
December 31, 2011
Study Completion Date
December 31, 2011
80/2.25 μg Symbicort pMDI
inhalation
80/4.5 μg Symbicort pMDI
inhalation
Foradil Aerolizer 12 μg
inhalation
40 μg budesonide HFA pMDI
inhalation
placebo HFA pMDI
inhalation
Research Site, Huntington
Research Site, Long Beach
Research Site, Mission Viejo
Research Site, Orange
Research Site, Rolling Hills Estate
Research Site, Sarasota
Research Site, Omaha
Research Site, Morrisville
Research Site, Raleigh
Research Site, Eugene
Research Site, Lake Oswego
Research Site, Medford
Research Site, Portland
Research Site, Altoona
Research Site, Upland
Research Site, Charleston
Research Site, El Paso
Research Site, San Antonio
Research Site, Waco
Research Site, Springfield
Research Site, Dublin
Research Site, Dublin
Research Site, Budapest
Research Site, Dublin
Research Site, Miskolc
Research Site, Sopron
Research Site, Dublin
Research Site, Krugersdorp
Research Site, Pietermariztburg
Research Site, Durban
Research Site, Cape Town
Research Site, Cape Town
Research Site, Claremont
Research Site, Dublin
Lead Sponsor
AstraZeneca
INDUSTRY